[1] Castleman B, Iverson L, Menendez VP.Localized mediastinal lymphnode hyperplasia resembling thymoma[J]. Cancer, 1956, 9(4): 822-830. [2] Lin JS, Chen CC, Liu CJ.Castleman's disease at parotid gland[J]. J Dent Sci, 2017, 12(1): 103-104. [3] 刘啸东, 刘维贤, 王秋旭. 腮腺区Castleman病1例及文献回顾 [J]. 临床口腔医学杂志, 2019, 35(10): 578, 636. [4] 程嘉, 周洁, 王国栋, 等. 头颈部Castleman病10例临床病理分析[J]. 中国口腔颌面外科杂志, 2016, 14(3): 257-262. [5] González García A, Moreno Cobo Má, Patier de la Peña JL. Current diagnosis and treatment of Castleman's disease[J]. Rev Clin Esp, 2016, 216(3):146-156. [6] Delaney SW, Zhou S, Maceri D.Castleman's disease presenting as a parotid mass in the pediatric population: a report of 2 cases[J]. Case Rep Otolaryngol, 2015, 2015: 691701. [7] Kumar S, Al Abri R, Kadir NA, et al.Castleman disease of the parotid gland in a pediatric patient: a case report[J]. Ear Nose Throat J, 2014, 93(10-11): E23-E25. [8] Bollig C, Moon S, Sujoy V, et al.Castleman disease of the parotid in childhood: a case report[J]. Am J Otolaryngol, 2014, 35(4): 517-519. [9] Udaquiola JE, Liberto DH, Kreindel TG, et al.Cervical Castleman's disease. Pediatric case report[J]. Arch Argent Pediatr, 2013, 111(4): e89-e93. [10] Lin CY, Chang YL.Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review[J]. J Formos Med Assoc, 2010, 109(12): 913-920. [11] Park JH, Lee SW, Koh YW.Castleman disease of the parotid gland in childhood: an unusual entity[J]. Auris Nasus Larynx, 2008, 35(3): 451-454. [12] Mohan H, Bal A, Tahlan A.Images in pathology. Castleman's disease of the parotid[J]. J Postgrad Med, 2003, 49(4): 348-349. [13] van Rhee F, Greenway A, Stone K. Treatment of idiopathic castleman disease[J]. Hematol Oncol Clin North Am, 2018, 32(1): 89-106. [14] Shivane A, Pearce A, Khatib N, et al.EBV+ HHV-8+ multicentric castleman disease with plasmablastic aggregates in an HIV+ man: an evolving clinicopathologic entity[J]. Int J Surg Pathol, 2018,26(4): 338-341. [15] Lyseng-Williamson KA.Siltuximab: A review in idiopathic (human herpesvirus-8-negative) multicentric castleman disease[J]. BioDrugs, 2015, 29(6): 399-406. [16] Yu L, Tu M, Cortes J, et al.Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease[J]. Blood, 2017, 129(12): 1658-1668. [17] Sun PP, Yu XJ, Wang SX, et al.Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease[J]. Nephrology (Carlton), 2020, 25(2): 125-134. [18] Liu X, Wang Q, Liu W. Castleman disease of the parotid gland: a case report [J]. J Oral Maxillofac Surg, 2020, 78(3):400.e1-400.e6. [19] Frizzera G.Castleman's disease and related disorders[J]. Semin Diagn Pathol, 1988, 5(4): 346-364. [20] Oksenhendler E, Boutboul D, Fajgenbaum D, et al.The full spectrum of Castleman disease: 273 patients studied over 20 years[J]. Br J Haematol, 2018, 180(2): 206-216. [21] Maslovsky I, Uriev L, Lugassy G.The heterogeneity of Castleman disease: report of five cases and review of the literature[J]. Am J Med Sci, 2000, 320(4): 292-295. [22] He X, Wang Q, Wu Y, et al.Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited[J]. Clin Oral Investig, 2018, 22(3): 1285-1295. |